Literature DB >> 32697005

Oral manifestations associated with COVID-19.

Milagros Díaz Rodríguez1, Amelia Jimenez Romera2, Mariana Villarroel3.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; fungal infections; immunosuppression; oral lesions; stress

Mesh:

Year:  2020        PMID: 32697005      PMCID: PMC7404436          DOI: 10.1111/odi.13555

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   4.068


× No keyword cloud information.
The appearance in December of a new coronavirus has caused an unprecedented pandemic in the modern era. Undoubtedly, the disease produced by the novel coronavirus and its consequences have posed a challenge for health authorities worldwide. The way of contagion through direct contact and through saliva in the form of small drops and the production of aerosols have facilitated the rapid spread worldwide. In Spain, the authorities declared the confinement for the majority of population in March 14; therefore, most of dental clinics were closed except for emergencies. Dentists were considered at high risk due to two factors: All procedures are obviously performed in the mouth with direct contact with saliva and the exposure to aerosols produced by rotatory instruments. Many articles have been published regarding the spread of the virus and the role that saliva plays in its transmission and diagnosis (Chen et al., 2020; Li et al., 2020; Sabino‐Silva, Jardim, & Siqueira, 2020; Xu et al., 2020a,2020b; Zhong et al., 2020). In relationship to extrapulmonary manifestations, several authors have reported cases with cutaneous manifestations in which maculo‐papular, acral, urticariform, vesicular, and vascular obstruction‐type manifestations are the most common (Estebanez et al., 2020; Galván Casas et al., 2020; Landa, Mendieta‐Eckert, Fonda‐Pascual, & Aguirre, 2020; Recalcati, 2020). During this period, despite the implications of saliva for virus transmission and the possibility of salivary glands as a reservoir, few oral manifestations have been reported. Oral dryness, vesiculobullous lesions, aphthous‐like lesions, dysgeusia, and anosmia are the most common oral signs reported (Martín Carreras‐Presas, Amaro Sánchez, López‐Sánchez, Jané‐Salas, & Somacarrera Pérez, 2020; Xu et al., 2020a,2020b). In this paper, we present 3 cases in which we have a confirmation for SARS‐CoV‐2 with oral manifestations. A 43‐year‐old woman tested positive for SARS‐CoV‐2 for 56 days, period in which several PCRs were performed. Patient developed fever, malaise, dysgeusia and anosmia, diarrhea, and pneumonia, and blood laboratories suggested risk of thrombosis. She was isolated and remained in quarantine during this period with regular follow‐ups by doctors over the phone. In the last 2 weeks, she reported aphthous‐like lesions, burning sensation, and tongue depapillation that progressed as observed in Figure 1. Image was sent through SMS with informed consent and data protection for sending images. In this case, we prescribed rinses with a solution containing triamcinolone acetonide 0.05%, 3 times a day for a 10‐day period. After treatment, lingual depapillation persisted but ulcers and burning sensation disappeared.
Figure 1

Bilateral atrophy of the surface of the tongue located in the lateral sides. Lateral dorsum appears depapillated with a symmetrical distribution

Bilateral atrophy of the surface of the tongue located in the lateral sides. Lateral dorsum appears depapillated with a symmetrical distribution A 53‐year‐old man tested positive for SARS‐CoV‐2, with hospital admission in the first week of April. A few days after hospital discharged, patient scheduled an appointment at the dental clinic for consultation. He referred burning mouth sensation and also unilateral commissural fissures (Figure 2). Complaining of anosmia and dysgeusia was recorded. Lesions were diagnosed as commissural cheilitis. In this case, we prescribed ointment containing neomycin, nystatin, and triamcinolone acetonide for application 3 times a day. Avoid self‐licking the area, as well as shaving, was recommended in order to diminish trauma. Hygiene of the area using a gauze with chlorhexidine between ointment application was also indicated. Commissural lesions disappeared completely after treatment, but anosmia and dysgeusia were still present.
Figure 2

Commissural cheilitis. Notice the fissure and bleeding located in the commissure

Commissural cheilitis. Notice the fissure and bleeding located in the commissure A 78‐year‐old woman tested positive for SARS‐CoV‐2, with hospital admission in the first days of April. Since hospitalization, she reported very intense sensation of dry mouth that she did not have previously. During dental consultation, lesions on the tongue, palate, and commissure compatible with pseudomembranous candidiasis and angular cheilitis were observed (Figure 3). In this case, we prescribed solutions and gels to improve salivary dryness. Nystatin solution rinses 4 times a day were prescribed for the intraoral lesions for 15 days. Angular cheilitis was treated using ointment containing neomycin, nystatin, and triamcinolone acetonide. After treatment, pseudomembranous lesions disappeared as well as commissural fissures. Moreover, salivary flow and dry mouth sensation improved.
Figure 3

Atrophy of the surface of the tongue including white fungal patches, distributed mainly in the left lateral side, and a red plate located in the hard and soft palate. Notice also the fissures located in the dorsum of the tongue

Atrophy of the surface of the tongue including white fungal patches, distributed mainly in the left lateral side, and a red plate located in the hard and soft palate. Notice also the fissures located in the dorsum of the tongue In relation to the cases reported, it should be noted that all of them are related to a certain state of immunosuppression. Stress might play an important role in the appearance of these oral conditions. Cause–effect relationship between coronavirus infection and the appearance of oral lesions cannot be established; however, as in HIV infection, COVID‐19 patients develop oral lesions related to immunosuppression more frequently. The reasons for absence of sufficient scientific evidence reporting oral lesions may be due to the confinement situation, lack of access to test therefore diagnosis confirmation, and the fact that most dentists, as a result of the high‐risk contagion, have been out of the health system. Nevertheless, telemedicine has been a useful tool to establish triage and primary diagnosis avoiding personal attendance during the peak of infection. It is important to consider that an exhaustive intraoral examination should be performed in patients that were diagnosed with COVID‐19 in order to find any oral manifestation that might be related. For instance, appearance of temporal oral pigmented lesions is expected as chloroquine has been used as part of the treatment in patients with COVID‐19. Also, dentist should improve the examination of salivary glands and saliva flow in order to perform early diagnoses related to changes in the glandular parenchyma that might be affected by the virus.

CONFLICT OF INTEREST

None to declare.

AUTHOR CONTRIBUTION

Milagros Diaz: Resources; Writing‐original draft; Writing‐review & editing. Amelia Jimenez: Resources; Supervision. Mariana Villarroel‐Dorrego: Supervision.

PEER REVIEW

The peer review history for this article is available at https://publons.com/publon/10.1111/odi.13555.
  10 in total

1.  Salivary Glands: Potential Reservoirs for COVID-19 Asymptomatic Infection.

Authors:  J Xu; Y Li; F Gan; Y Du; Y Yao
Journal:  J Dent Res       Date:  2020-04-09       Impact factor: 6.116

2.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

3.  Chilblain-like lesions on feet and hands during the COVID-19 Pandemic.

Authors:  Nerea Landa; Marta Mendieta-Eckert; Pablo Fonda-Pascual; Teresa Aguirre
Journal:  Int J Dermatol       Date:  2020-04-24       Impact factor: 2.736

4.  Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis.

Authors:  Robinson Sabino-Silva; Ana Carolina Gomes Jardim; Walter L Siqueira
Journal:  Clin Oral Investig       Date:  2020-02-20       Impact factor: 3.573

5.  Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients.

Authors:  Lili Chen; Jiajia Zhao; Jinfeng Peng; Xiaoshuang Li; Xuliang Deng; Zhi Geng; Zhenyu Shen; Fengyuan Guo; Qianwen Zhang; Yang Jin; Lin Wang; Songlin Wang
Journal:  Cell Prolif       Date:  2020-10-19       Impact factor: 6.831

6.  Oral vesiculobullous lesions associated with SARS-CoV-2 infection.

Authors:  Carmen Martín Carreras-Presas; Juan Amaro Sánchez; Antonio Francisco López-Sánchez; Enric Jané-Salas; Maria Luisa Somacarrera Pérez
Journal:  Oral Dis       Date:  2020-05-29       Impact factor: 4.068

Review 7.  Saliva is a non-negligible factor in the spread of COVID-19.

Authors:  Yuqing Li; Biao Ren; Xian Peng; Tao Hu; Jiyao Li; Tao Gong; Boyu Tang; Xin Xu; Xuedong Zhou
Journal:  Mol Oral Microbiol       Date:  2020-05-31       Impact factor: 4.107

8.  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Authors:  C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval
Journal:  Br J Dermatol       Date:  2020-06-10       Impact factor: 11.113

Review 9.  Saliva: potential diagnostic value and transmission of 2019-nCoV.

Authors:  Ruoshi Xu; Bomiao Cui; Xiaobo Duan; Ping Zhang; Xuedong Zhou; Quan Yuan
Journal:  Int J Oral Sci       Date:  2020-04-17       Impact factor: 6.344

Review 10.  Cutaneous manifestations in COVID-19: a new contribution.

Authors:  A Estébanez; L Pérez-Santiago; E Silva; S Guillen-Climent; A García-Vázquez; M D Ramón
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228

  10 in total
  27 in total

1.  [Translated article] Oral Findings in Patients With COVID-19.

Authors:  M Villarroel-Dorrego; L Chacón; R Rosas; V Barrios; Y Pernía; H Vélez
Journal:  Actas Dermosifiliogr       Date:  2022-02

2.  Histopathological analysis of soft tissue changes in gingival biopsied specimen from patients with underlying corona virus disease associated mucormycosis (CAM).

Authors:  D Pandiar; P Ramani; R-P Krishnan; D Y
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-05-01

3.  Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.

Authors:  Kausar Sadia Fakhruddin; Lakshman Perera Samaranayake; Borvornwut Buranawat; Hien Ngo
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

4.  An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.

Authors:  Heron Gezahegn Gebretsadik
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

5.  COVID tongue.

Authors:  R W Hathway
Journal:  Br Dent J       Date:  2021-02       Impact factor: 1.626

Review 6.  Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.

Authors:  Shahroo Etemad-Moghadam; Mojgan Alaeddini
Journal:  Int J Dent       Date:  2021-05-18

7.  Tongue ulcer in a patient with COVID-19: a case presentation.

Authors:  Mohammad Bashir Nejabi; Noor Ahmad Shah Noor; Nahid Raufi; Mohammad Yasir Essar; Ehsanullah Ehsan; Jaffer Shah; Asghar Shah; Arash Nemat
Journal:  BMC Oral Health       Date:  2021-05-20       Impact factor: 2.757

8.  Angular cheilitis of COVID-19 patients: A case-series and literature review.

Authors:  Abanoub Riad; Islam Kassem; Julien Issa; Mai Badrah; Miloslav Klugar
Journal:  Oral Dis       Date:  2020-10-23       Impact factor: 4.068

9.  Renin-angiotensin II-aldosterone axis in SARS-CoV-2-associated xerostomia.

Authors:  Gulshan Sunavala-Dossabhoy
Journal:  Oral Dis       Date:  2020-08-31       Impact factor: 4.068

10.  Could the oral cavity be a target organ in SARS-CoV-2 infection?

Authors:  Satish Kumar
Journal:  Evid Based Dent       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.